Medicared For All Logo

Shahriar Dadkhah MD in Lincolnwood, Illinois

Home Illinois Lincolnwood

Shahriar Dadkhah MD has Cardiovascular Disease (cardiology) as his primary medical specialty. Their primary office is: 7126 N Lincoln Ave in Lincolnwood, Illinois.

They're a part of the: Shahriar Dadkhah, Md, Sc medical group which has around 2 members. You can call their office at 847-864-6666 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1987 (around 37 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Shahriar Dadkhah MD Office Phone and Directions

Shahriar Dadkhah MD
Shahriar Dadkhah, Md, Sc
7126 N Lincoln Ave
Lincolnwood, Illinois 60712
847-864-6666


Patient Ratings
Please rate your experience with Shahriar Dadkhah MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 847-864-6666


Enter a starting address:


Healthcare Info for Shahriar Dadkhah MD

Additional Medical Specialties Include:
INTERNAL MEDICINE, INTERVENTIONAL CARDIOLOGY

Medical School: Sorry, his university is not listed
Graduation Year: 1987
The Primary Medical Specialty for Shahriar Dadkhah MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 37
PAC (PECOS ID)#: 8921094988
NPI #: 1063469641
NPI Created On: 05/28/2006
NPI Last Updated Listed as: 01/24/2013
Primary Taxonomy Code: 207RC0000X
License Number:
036082937
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, Farsi, Persian.


Services and Procedures include:

  1. External ekg recording for more than 48 hours up to 21 days
  2. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
  3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
  4. Routine ekg using at least 12 leads including interpretation and report
  5. Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report
  6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
  7. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision
  8. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report
  9. Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days
  10. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  11. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
  12. Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
  13. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
  14. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
  15. Established patient office or other outpatient, visit typically 25 minutes
  16. Established patient office or other outpatient, visit typically 40 minutes
  17. Initial hospital inpatient care, typically 70 minutes per day
  18. Subsequent hospital inpatient care, typically 35 minutes per day
  19. Technetium tc-99m sestamibi, diagnostic, per study dose
  20. Injection, regadenoson, 0.1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $26

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788985885

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788985887

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788985889

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 812649307

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: ENTRESTO

Open Associated Drug #1: 0078-0659-20


Payments Total: $27

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825780941

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Cardiology

Name of Drug #1: Repatha

Open Associated Drug #1: 72511-760-02


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825780945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Cardiology

Name of Drug #1: Repatha

Open Associated Drug #1: 72511-760-02


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 825780949

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Cardiology

Name of Drug #1: Repatha

Open Associated Drug #1: 72511-760-02


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848483629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: VERQUVO

Open Associated Drug #1: 0006-5030-01


Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848591029

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: VERQUVO

Open Associated Drug #1: 0006-5030-01


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 848686611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR

Name of Drug #1: VERQUVO

Open Associated Drug #1: 0006-5030-01


Providers in Shahriar Dadkhah, Md, Sc

1.Shahriar Dadkhah Md

7126 N Lincoln Ave
Lincolnwood Il 60712-2234
Shahriar Dadkhah, Md, Sc
Cardiovascular Disease (cardiology)

2.Roza Sharain

7126 N Lincoln Ave
Lincolnwood Il 60712-2234
Shahriar Dadkhah, Md, Sc
Nurse Practitioner

View all 2 members of Shahriar Dadkhah, Md, Sc medical group